×
Choose Speciality

EXPLORE!

LOGIN

By signing up or signing in to eMediNexus, you consent to eMediNexus collecting and using your personal data in accordance with our Privacy Policy. We are committed to safeguarding your information and ensuring the highest standards of data protection. Your trust and privacy are of utmost importance to us.

US FDA approves plecanatide for IBS with constipation in adults

  825 Views

eMediNexus    27 January 2018

The US Food and Drug Administration (FDA) has approved plecanatide 3 mg tablets (Trulance, Synergy Pharmaceuticals) for treatment of irritable bowel syndrome with constipation (IBS-C) in adults. The drug is contraindicated in children younger than 6 years and should be avoided in patients younger than 18 years.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.